Home LiteratureArticle Details
PMID: 12406738 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule.

Applied and environmental microbiology ·Vol. 68 ·No. 11 ·2002-11-00 ·Pages 5459-63

Ramage G, Saville SP, Wickes BL, López-Ribot JL

Abstract

Farnesol is a quorum-sensing molecule that inhibits filamentation in Candida albicans. Both filamentation and quorum sensing are deemed to be important factors in C. albicans biofilm development. Here we examined the effect of farnesol on C. albicans biofilm formation. C. albicans adherent cell populations (after 0, 1, 2, and 4 h of adherence) and preformed biofilms (24 h) were treated with various concentrations of farnesol (0, 3, 30, and 300 micro M) and incubated at 37 degrees C for 24 h. The extent and characteristics of biofilm formation were then assessed microscopically and with a semiquantitative colorimetric technique based on the use of 2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide. The results indicated that the effect of farnesol was dependent on the concentration of this compound and the initial adherence time, and preincubation with 300 micro M farnesol completely inhibited biofilm formation. Supernatant media recovered from mature biofilms inhibited the ability of planktonic C. albicans to form filaments, indicating that a morphogenetic autoregulatory compound is produced in situ in biofilms. Northern blot analysis of RNA extracted from cells in biofilms indicated that the levels of expression of HWP1, encoding a hypha-specific wall protein, were decreased in farnesol-treated biofilms compared to the levels in controls. Our results indicate that farnesol acts as a naturally occurring quorum-sensing molecule which inhibits biofilm formation, and we discuss its potential for further development and use as a novel therapeutic agent.

MeSH Terms
Animals Biofilms/drug effects,growth & development Blotting, Northern Candida albicans/drug effects,physiology,ultrastructure Cell Communication Farnesol/pharmacology Microscopy, Electron, Scanning Plankton/physiology
Chemicals
Farnesol
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Ramage Gordon
Department of Microbiology. Department of Medicine, Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78245, USA.
Saville Stephen P
Wickes Brian L
López-Ribot José L
References (29)
29 references, click to expand
  1. Intravascular-catheter-related infections.
    Lancet. 1998 Mar 21;351(9106):893-8 PMID: 9525387
  2. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol.
    Appl Environ Microbiol. 2001 Jul;67(7):2982-92 PMID: 11425711
  3. Nonfilamentous C. albicans mutants are avirulent.
    Cell. 1997 Sep 5;90(5):939-49 PMID: 9298905
  4. N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms.
    Microbiology. 2001 Dec;147(Pt 12):3249-62 PMID: 11739757
  5. Microbial findings at failing implants.
    Clin Oral Implants Res. 1999 Oct;10(5):339-45 PMID: 10551058
  6. The involvement of cell-to-cell signals in the development of a bacterial biofilm.
    Science. 1998 Apr 10;280(5361):295-8 PMID: 9535661
  7. Nosocomial enterococcal blood stream infections in the SCOPE Program: antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy. SCOPE Hospital Study Group.
    Diagn Microbiol Infect Dis. 1997 Oct;29(2):95-102 PMID: 9368085
  8. Role of dimorphism in the development of Candida albicans biofilms.
    J Med Microbiol. 1999 Jul;48(7):671-9 PMID: 10403418
  9. Impact of the changing epidemiology of fungal infections in the 1990s.
    Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):287-91 PMID: 1396747
  10. Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene.
    Mol Microbiol. 1999 Nov;34(4):651-62 PMID: 10564506
  11. Regulatory networks controlling Candida albicans morphogenesis.
    Trends Microbiol. 1999 Aug;7(8):333-8 PMID: 10431207
  12. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.
    Am J Med. 1991 Sep 16;91(3B):86S-89S PMID: 1928197
  13. Candida albicans infection of prosthetic joints.
    Orthopedics. 1996 Mar;19(3):247-51 PMID: 8867552
  14. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.
    J Antimicrob Chemother. 2002 Jun;49(6):973-80 PMID: 12039889
  15. Biofilms of Candida albicans and their associated resistance to antifungal agents.
    Am Clin Lab. 2001 Aug;20(7):42-4 PMID: 11570274
  16. Candida albicans strains heterozygous and homozygous for mutations in mitogen-activated protein kinase signaling components have defects in hyphal development.
    Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13223-8 PMID: 8917572
  17. Candida'the cancer of silastic'.
    J Laryngol Otol. 1996 Mar;110(3):240-2 PMID: 8730359
  18. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms.
    Antimicrob Agents Chemother. 2001 Sep;45(9):2475-9 PMID: 11502517
  19. Intravascular catheter-associated infections.
    Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):1-8 PMID: 10706172
  20. Characteristics of biofilm formation by Candida albicans.
    Rev Iberoam Micol. 2001 Dec;18(4):163-70 PMID: 15496122
  21. Isolation and purification of morphogenic autoregulatory substance produced by Candida albicans.
    J Biochem. 1983 Sep;94(3):777-83 PMID: 6358202
  22. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms.
    Nature. 2000 Oct 12;407(6805):762-4 PMID: 11048725
  23. Microbiology: breaking down biofilms.
    Curr Biol. 2002 Feb 19;12(4):R132-4 PMID: 11864585
  24. Overview of microbial biofilms.
    J Ind Microbiol. 1995 Sep;15(3):137-40 PMID: 8519468
  25. Quorum sensing signals in development of Pseudomonas aeruginosa biofilms.
    Methods Enzymol. 1999;310:43-55 PMID: 10547781
  26. Quorum sensing in bacteria.
    Annu Rev Microbiol. 2001;55:165-99 PMID: 11544353
  27. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.
    Diagn Microbiol Infect Dis. 1998 May;31(1):327-32 PMID: 9597393
  28. Genetic organization and sequence analysis of the hypha-specific cell wall protein gene HWP1 of Candida albicans.
    Yeast. 1998 May;14(7):681-6 PMID: 9639315
  29. Candida albicans: genetics, dimorphism and pathogenicity.
    Int Microbiol. 1998 Jun;1(2):95-106 PMID: 10943347
Article Info
Journal
Applied and environmental microbiology
Abbr.
Appl Environ Microbiol
ISSN
0099-2240
Published
2002-11-00
Pages
5459-63
Language
English
Region
United States
NLM ID
7605801
PMCID
PMC129887
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]